Developing new products, technologies and innovations which benefit patients while relieving pressure on healthcare organisations. We’re committed to harnessing the power of Artificial Intelligence (AI), machine learning and digital technologies to continually improve our offerings to address unmet needs.
- A broad insulin range available to support the treatment needs of people living with diabetes at every stage of their journey. Our insulins are priced to offer value across both our branded and biosimilar portfolio, delivering significant and meaningful savings to the health service
- Continuous development of new vaccines, technologies and innovations which benefit patients while relieving pressure on healthcare systems
- Partnering with tech firms and with the NHS through the Academic Health Science Network (AHSN) to develop an AI-driven solution to support the unmet mental health needs of people with chronic conditions which we aim to launch in 2023